Federation des caisses Desjardins du Quebec’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-200	Closed	-$3.7K	–	2557
2022 Q3	$3.7K	Hold	200	–	–	﹤0.01%	2146
2022 Q2	$2.63K	Hold	200	–	–	﹤0.01%	2263
2022 Q1	$1.85K	Hold	200	–	–	﹤0.01%	2372
2021 Q4	$1.95K	Sell	200 -408	-67%	-$7.67K	﹤0.01%	2359
2021 Q3	$20.7K	Hold	608	–	–	﹤0.01%	1847
2021 Q2	$22.3K	Buy	608 +200	+49%	+$7.74K	﹤0.01%	1827
2021 Q1	$18.3K	Buy	+408	New	+$19K	﹤0.01%	1836

Other funds holding DCPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's DCPH Position: Q4 2022 in Review

Federation des caisses Desjardins du Quebec sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2022, closing a stake of 200 shares — an estimated $3.7K sold.

Federation des caisses Desjardins du Quebec first reported a position in DCPH in Q1 2021 and held it in 7 quarters. The position peaked at $22.3K in Q2 2021. 143 funds tracked by Wall St. Rank hold DCPH as of Q4 2022.

Federation des caisses Desjardins du Quebec reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 200 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $3.7K.
Federation des caisses Desjardins du Quebec first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 7 quarters.
Federation des caisses Desjardins du Quebec's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $22.3K in Q2 2021.
143 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q4 2022, filed 15 Aug 2024.